|
|
|
|
Screening Test for Traumatic Brain Injury
Axelas dotLab System Is Being Used to Measure Levels of Neuron-Specific Enolase in ER Setting Galina Bernstein, Ph.Wei Hu, Ph. Traumatic brain injury (TBI) is called a silent epidemic. The Centers for Disease Control and...
|
|
|
Caring for the most vulnerable
The provision of patient services in Our Ladys Hospice, Harolds Cross, Dublin, can be divided into four sub-divisions.First is our Extended Care Division which houses approximately 105 elderly patients, who have profound neurological...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease.The trial did not demonstrate an appreciable difference...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
SAN DIEGO, Nov.26 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not...
|
|
|
Diverse Symptoms Of Prion Disease In Humans Replicated In Mouse Model
CJD / vCJD / Mad Cow Disease News Main Category: CJD / vCJD / Mad Cow Disease Also Included In: Biology / Biochemistry; Neurology / Neuroscience email to a friend printer friendly view / write opinions rate article Current...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
SAN DIEGO, Nov.26 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not...
|
|
|
Friends fight ALS through their online children's boutique
Two Chesterfield women have become big stars for a local charity thanks to their 2littlestars.com online childrens boutique.The Web site, operated since September and founded by Lisa Callanan and Christina Tedesco, specializes in...
|
|
|
Nitric oxide can change computational ability of the brain
Medical Research News Research from the Medical Research Council (MRC) Toxicology Unit at the University of Leicester shows that nitric oxide (NO) can change the computational ability of the brain.This finding has implications for the...
|
|
|
Ceregene announces data from phase 2 clinical trial of CERE-120 for Parkinson's
Ceregene, Inc., a biopharmaceutical company, has reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease.The trial did not demonstrate an appreciable difference...
|
|
|
Cause And Possible Treatment Of Motor Neurone Disease Illuminated
ScienceDaily (Nov.27, 2008) BBSRC-funded researchers at UCL along with collaborators at King's College London have identified a molecule that could be the key to understanding the cause of neurodegenerative diseases such as motor ...
|
|
|
Mouse Model Of Prion Disease Mimics Diverse Symptoms Of Human Disorder
ScienceDaily (Nov.26, 2008) A comprehensive mouse model of inherited prion disease exhibits cognitive, motor, and neurophysiological deficits that bear a striking resemblance to the symptoms experienced by patients with the human...
|
|
|
Alzheimer's Drug Discovery Foundation Funds Varinel To Develop Drugs For Neurodegenerative Disease
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it provided a grant of $185,000 to Varinel, Inc., an emerging pharmaceutical company dedicated to developing drugs that can prevent neuronal degeneration and improve...
|
|
|
Studying how nitric oxide alters brain function can lead to Alzheimer's treatment
A team of British researchers has found that nitric oxide (NO) can change the computational ability of the brain.Experts at the Medical Research Council (MRC) Toxicology Unit at the University of Leicester say that their new finding has...
|
|
|
Nitric Oxide Can Alter Brain Function
Research from the Medical Research Council (MRC) Toxicology Unit at the University of Leicester shows that nitric oxide (NO) can change the computational ability of the brain.This finding has implications for the treatment of...
|
|
|
Nitric Oxide Can Alter Brain Function
ScienceDaily (Nov.26, 2008) Research from the Medical Research Council (MRC) Toxicology Unit at the University of Leicester shows that nitric oxide (NO) can change the computational ability of the brain. This finding has implications...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial Of CERE-120 For Parkinson's Disease
Ceregene, Inc., a biopharmaceutical company, reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease.The trial did not demonstrate an appreciable difference between...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
SAN DIEGO, Nov.26 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
SAN DIEGO 'On behalf of everyone at Ceregene, I would like to personally express my gratitude to all the patients, physicians and staff who participated in this study.We share their disappointment. We also offer our heartfelt...
|
|
|
Mouse model of prion disease mimics diverse symptoms of human disorder
A comprehensive mouse model of inherited prion disease exhibits cognitive, motor, and neurophysiological deficits that bear a striking resemblance to the symptoms experienced by patients with the human version of 'mad cow disease,'...
|
|
|
Nitric Oxide Can Alter Brain Function
Finding has implications for the treatment of neurodegenerative disease and dementia LEICESTER, England, Nov.26,2008--Research from the Medical Research Council (MRC) Toxicology Unit at the University of Leicester shows that nitric oxide ...
|
|
|
Nitric oxide can alter brain function
Research from the Medical Research Council (MRC) Toxicology Unit at the shows that nitric oxide (NO) can change the computational ability of the brain.This finding has implications for the treatment of neurodegenerative diseases such as...
|
|
|
Nitric oxide can alter brain function
Research from the Medical Research Council (MRC) Toxicology Unit at the shows that nitric oxide (NO) can change the computational ability of the brain.This finding has implications for the treatment of neurodegenerative diseases such as...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
SAN DIEGO, Nov.26 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
SAN DIEGO, Nov.26 /PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease. The trial did not...
|
|
|
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
/PRNewswire/ -- Ceregene, Inc., a biopharmaceutical company, today reported clinical data from a double-blind, controlled Phase 2 trial of CERE-120 in 58 patients with advanced Parkinson's disease.The trial did not demonstrate an...
|
